What Is Retinopathy?

Retinopathy is a disease process affecting the retina, the light-sensitive neural tissue at the back of the eye, in which pathological changes to retinal blood vessels or neural cells impair visual function and can lead to blindness if untreated. The term encompasses a broad class of conditions distinguished by their underlying cause: metabolic disorders, hypertension, premature birth, drug toxicity, radiation, and hereditary degeneration all produce characteristic retinopathies with distinct patterns of vascular and tissue damage. Retinopathy is one of the leading causes of preventable vision loss worldwide, and its clinical diagnosis has become a major application domain for biomedical imaging and machine learning, making it a prominent topic in IEEE biomedical engineering research.

Diabetic Retinopathy

Diabetic retinopathy (DR) is the most prevalent and extensively studied form of the disease, affecting a substantial proportion of individuals with diabetes mellitus over time and representing a leading cause of working-age blindness globally. The underlying mechanism is chronic hyperglycemia causing damage to the pericytes and endothelial cells of retinal capillaries, progressively compromising the blood-retinal barrier. Non-proliferative diabetic retinopathy (NPDR) presents first as microaneurysms (small focal outpouchings of capillary walls), followed by dot and blot hemorrhages, hard exudates from plasma lipid leakage, and cotton-wool spots indicating focal ischemia. In proliferative diabetic retinopathy (PDR), retinal ischemia triggers the growth of fragile new vessels on the retinal surface and into the vitreous humor; these neovascular structures are prone to bleeding and contracture, causing vitreous hemorrhage and tractional retinal detachment. The standard clinical grading scale, developed by the Early Treatment Diabetic Retinopathy Study (ETDRS), assigns severity levels from mild NPDR to high-risk PDR based on lesion type and extent. Imaging biomarkers including capillary dropout area, foveal avascular zone (FAZ) enlargement, and microvascular caliber alterations detected by optical coherence tomography angiography (OCTA) are now recognized as early markers of DR progression, as reviewed in advances in structural and functional retinal imaging for early diabetic retinopathy detection.

Other Forms of Retinopathy

Hypertensive retinopathy arises from chronically elevated blood pressure, producing arteriolar narrowing, arteriovenous nicking (where arterioles cross and compress veins), flame-shaped hemorrhages, and, in severe cases, papilledema (swelling of the optic disc) that signals hypertensive emergency. Retinopathy of prematurity (ROP) affects premature infants whose retinal vascularization is incomplete at birth; exposure to supplemental oxygen and the subsequent relative hypoxia of normal air can trigger abnormal neovascularization at the boundary between vascularized and avascular retina. ROP remains a major cause of childhood blindness in both high-income countries with access to intensive neonatal care and in middle-income countries where oxygen delivery is less well controlled. Radiation retinopathy and drug-induced retinopathy (associated with agents such as chloroquine and hydroxychloroquine) produce more diffuse damage through direct toxicity to retinal cells and vasculature.

Automated Detection and AI

The need to screen large diabetic populations for DR has driven substantial engineering investment in automated retinopathy detection. Convolutional neural networks trained on large datasets of labeled fundus photographs now achieve area under the ROC curve above 0.99 for detecting referable diabetic retinopathy in controlled settings. The FDA has cleared AI-based autonomous DR screening systems, including the IDx-DR system, for use without requiring a clinician to interpret each image in real time. Multimodal approaches combining fundus photography, OCT, and OCTA improve sensitivity for early disease by integrating structural and perfusion information. A survey of automated detection of diabetic retinopathy in retinal images catalogues the machine learning approaches developed through the mid-2010s, while more recent work is reviewed in novel artificial intelligence methods for diabetic retinopathy and diabetic macular edema, including large language model-assisted diagnostic pipelines.

Applications

Retinopathy research and detection systems have applications in a wide range of clinical and public health contexts, including:

• Population-scale diabetic retinopathy screening using automated fundus photograph analysis in primary care and pharmacy settings
• Telemedicine ophthalmology programs that deliver specialist-level retinal assessment to rural and underserved communities
• Clinical trial imaging endpoints for anti-VEGF (vascular endothelial growth factor) therapies targeting diabetic macular edema and proliferative DR
• Neonatal intensive care protocols for ROP surveillance in very low birthweight infants
• Hypertension monitoring via retinal biomarkers as a complement to blood pressure measurement